Notably, several recent studies have demonstrated the neuroprotective effect of OM-MSCs against cerebral IRI [19–21], one of which preliminarily suggested OM-MSC-mediated restoration of SPCA1 expression and reduction of GA dissolution in ischemic stroke rats [21]. The gene discussed is ATP2C1; the disease is ischemic stroke.